Skip to main content
OpenTrials

Clinical trial condition

Hidradenitis Suppurativa

Explore clinical trials studying Hidradenitis Suppurativa. Study availability and eligibility vary by location and protocol.

220 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Hidradenitis Suppurativa trial results

Active, not recruiting

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

NCT07228390

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Specialty Building Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
View all 67 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06212999

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Investigative Site US303 Phoenix, Arizona, United States
  • Investigative Site US240 Scottsdale, Arizona, United States
  • Investigative Site US307 Fort Smith, Arkansas, United States
  • Investigative Site US214 Rogers, Arkansas, United States
View all 165 locations
View Trial Details
Active, not recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

NCT06840392

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations
  • Total Skin and Beauty Dermatology Center PC Birmingham, Alabama, United States
  • CTT Research Gilbert, Arizona, United States
  • Ctr for Dermatology Clinical Res Fremont, California, United States
  • USC Keck School of Medicine Los Angeles, California, United States
View all 130 locations
View Trial Details
Active, not recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

NCT06799000

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • Cheryl Effron MD Inc Anaheim, California, United States
View all 139 locations
View Trial Details
Active, not recruiting

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT05889182

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Cahaba Dermatology & Skin Health Center /ID# 254876 Birmingham, Alabama, United States
  • Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272564 Fountain Hills, Arizona, United States
  • Medical Dermatology Specialists /ID# 254226 Phoenix, Arizona, United States
  • Mayo Clinic - Scottsdale /ID# 254388 Scottsdale, Arizona, United States
View all 285 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

NCT06959225

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Investigative Site US020 Phoenix, Arizona, United States
  • Investigative Site US033 Scottsdale, Arizona, United States
  • Investigative Site US054 Tempe, Arizona, United States
  • Investigative Site US002 Fayetteville, Arkansas, United States
View all 101 locations
View Trial Details
Active, not recruiting

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

NCT05921994

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Rheinstetten, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Haßfurt, Bavaria, Germany
  • Novartis Investigative Site Kulmbach, Bavaria, Germany
View all 80 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

NCT06958211

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Investigative Site US257 Birmingham, Alabama, United States
  • Investigative Site US218 Birmingham, Alabama, United States
  • Investigative Site US239 Montgomery, Alabama, United States
  • Investigative Site US215 Phoenix, Arizona, United States
View all 107 locations
View Trial Details
Active, not recruiting

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

NCT06993610

Conditions
Acne Vulgaris, Acneiform Eruptions, Bacterial Infections, +13 more
Locations
  • Medical Dermatology Specialists (Phoenix) Phoenix, Arizona, United States
  • First OC Dermatology Research, Inc. Irvine, California, United States
  • Wallace Medical Group, Inc. Los Angeles, California, United States
  • Northridge Clinical Trials Northridge, California, United States
View all 61 locations
View Trial Details

Related conditions